Marshall Wace’s Esperion Therapeutics ESPR Stock Holding History

Marshall Wace’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.4M	Buy	7,075,083 +1,603,472	+29%	+$5.08M	0.02%	716
2025 Q4	$20.2M	Buy	5,471,611 +2,950,172	+117%	+$9.53M	0.02%	623
2025 Q3	$6.68M	Sell	2,521,439 -2,790,813	-53%	-$5.4M	0.01%	1083
2025 Q2	$5.21M	Buy	5,312,252 +1,679,294	+46%	+$1.68M	0.01%	1119
2025 Q1	$5.23M	Buy	+3,632,958	New	+$6.69M	0.01%	1042
2024 Q4	–	Sell	-3,092,629	Closed	-$5.1M	–	2707
2024 Q3	$5.1M	Sell	3,092,629 -1,210,967	-28%	-$2.45M	0.01%	992
2024 Q2	$9.55M	Buy	4,303,596 +2,087,635	+94%	+$4.91M	0.01%	749
2024 Q1	$5.94M	Buy	2,215,961 +1,758,203	+384%	+$4.27M	0.01%	933
2023 Q4	$1.37M	Sell	457,758 -1,116,378	-71%	-$1.45M	﹤0.01%	1367
2023 Q3	$1.54M	Buy	1,574,136 +1,258,207	+398%	+$1.82M	﹤0.01%	1345
2023 Q2	$439K	Buy	315,929 +28,324	+10%	+$39.5K	﹤0.01%	2026
2023 Q1	$457K	Buy	287,605 +112,582	+64%	+$581K	﹤0.01%	2143
2022 Q4	$1.09M	Sell	175,023 -385,964	-69%	-$2.76M	﹤0.01%	2047
2022 Q3	$3.76M	Buy	560,987 +534,387	+2,009%	+$3.67M	0.01%	1584
2022 Q2	$169K	Buy	+26,600	New	+$151K	﹤0.01%	3205
2021 Q4	–	Sell	-520,095	Closed	-$6.27M	–	3990
2021 Q3	$6.27M	Sell	520,095 -651,975	-56%	-$9.49M	0.03%	816
2021 Q2	$24.8M	Buy	1,172,070 +142,369	+14%	+$3.43M	0.13%	192
2021 Q1	$28.9M	Sell	1,029,701 -346,229	-25%	-$10.2M	0.15%	158
2020 Q4	$35.8M	Buy	1,375,930 +9,825	+0.7%	+$294K	0.23%	110
2020 Q3	$50.8M	Buy	1,366,105 +75,331	+6%	+$2.98M	0.37%	61
2020 Q2	$66.2M	Sell	1,290,774 -33,173	-3%	-$1.39M	0.52%	44
2020 Q1	$41.7M	Buy	+1,323,947	New	+$69.9M	0.42%	47
2019 Q2	–	Sell	-4,635	Closed	-$186K	–	1481
2019 Q1	$186K	Buy	+4,635	New	+$208K	﹤0.01%	1343
2015 Q3	–	Sell	-12,182	Closed	-$996K	–	960
2015 Q2	$996K	Sell	12,182 -103,956	-90%	-$10.2M	0.01%	602
2015 Q1	$10.8M	Buy	116,138 +110,425	+1,933%	+$7.13M	0.14%	188
2014 Q4	$231K	Buy	+5,713	New	+$175K	﹤0.01%	736